Real-world prognostic factors for first-line EGFR-TKI efficacy in advanced NSCLC patients harboring EGFR 21 L858R mutation by Yan’e Liu, Lu Chen, Xin Zhu, Hua Zhang, Baoshan Cao

Get full text

Targeting KRAS: from metabolic regulation to cancer treatment by Yanyan Shi, Huiling Zheng, Tianzhen Wang, Shengpu Zhou, Shiqing Zhao, Mo Li, Baoshan Cao

Get full text

The global progress and quality assessment of research on the association between circulating tumor DNA and clinical prognosis: a systematic review by Meng Zhang, Xiaowei Chen, Qingxin Zhou, Nana Guo, Baoshan Cao, Hongmei Zeng, Wanqing Chen, Feng Sun

Get full text

A comprehensive comparison of third generation epidermal growth factor receptor tyrosine kinase inhibitors in the treatment efficacy and adverse events: A Bayesian meta-analysis by Jinyu Yu, PhD, Hanyu Wu, BS, Lu Yang, MD, Wei Liu, PhD, Baoshan Cao, MD, Baosheng Liang, PhD, Yangchun Gu, MD

Get full text

Liver protection of CACA technical guidelines for holistic integrative management of cancer by Ningning Zhang, Lungen Lu, Baoshan Cao, Yanjing Gao, Feng Han, Liangping Li, Qijiong Li, Shuchen Li, Xiaowu Li, Jingfeng Liu, Yefu Liu, Yingqian Lv, Yongzhan Nie, Xizhong Shen, Dongde Wu, Qiang Wu, Jun Xu, Liping Yao, Ning Zhang, Yuzheng Zhuge, Xiubao Ren, De’an Tian, Guohong Han, Wei Lu, Oncology Hepatology Committee of China Anti-Cancer Association

Get full text